• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一例霍奇金淋巴瘤出现红皮病,可能是对长春花生物碱过敏反应所致]

[A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids].

作者信息

Matsumoto N, Yoshimoto K, Okagawa K, Kosaka M, Saito S

机构信息

First Dept. of Internal Medicine, School of Medicine, University of Tokushima.

出版信息

Gan To Kagaku Ryoho. 1989 Jun;16(6):2297-300.

PMID:2525367
Abstract

A 58-year-old man with Hodgkin's disease exhibited erythrodermia due to allergic reaction to vincristine sulfate (VCR) and vindesine sulfate (VDS). However, chemotherapy could be continued by changing VCR and VDS to etoposide without allergic symptom. Clinical observation strongly suggested that erythrodermia was due to the use of vinca alkaloids in this patient. Hematological and neurological side effects have been well known for VDS and VCR, but erythrodermia has not yet been reported as being caused by these agents. It is often difficult to differentiate drugs as a cause of an allergic reaction when several drugs are used together. Therefore, it is important to collect all the cases showing the effects of drugs.

摘要

一名58岁的霍奇金病患者因对硫酸长春新碱(VCR)和硫酸长春地辛(VDS)过敏反应而出现红皮病。然而,通过将VCR和VDS换为依托泊苷,化疗得以继续且未出现过敏症状。临床观察强烈提示该患者的红皮病是由于使用长春花生物碱所致。VDS和VCR的血液学和神经学副作用已为人熟知,但红皮病尚未见报道由这些药物引起。当同时使用几种药物时,往往难以区分药物作为过敏反应的原因。因此,收集所有显示药物作用的病例很重要。

相似文献

1
[A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids].[一例霍奇金淋巴瘤出现红皮病,可能是对长春花生物碱过敏反应所致]
Gan To Kagaku Ryoho. 1989 Jun;16(6):2297-300.
2
Acute allergic reaction due to vincristine sulfate. A case report.硫酸长春新碱引起的急性过敏反应。病例报告。
Oncology. 1984;41(6):403-5. doi: 10.1159/000225864.
3
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.晚期霍奇金淋巴瘤采用MOPPEBVCAD化疗联合有限及有条件放疗:10年结果、晚期毒性及第二肿瘤
Clin Cancer Res. 2006 Jan 15;12(2):529-35. doi: 10.1158/1078-0432.CCR-05-1707.
4
MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
Haematologica. 1993 Jan-Feb;78(1):44-8.
5
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.ABVD方案对比改良斯坦福V方案对比MOPPEBVCAD方案并联合选择性和局限性放疗用于中晚期霍奇金淋巴瘤:意大利淋巴瘤协作组多中心随机试验的最终结果
J Clin Oncol. 2005 Dec 20;23(36):9198-207. doi: 10.1200/JCO.2005.02.907. Epub 2005 Sep 19.
6
[Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
Gan To Kagaku Ryoho. 1996 Mar;23(4):499-501.
7
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.在晚期霍奇金淋巴瘤的MOPPEBVCAD化疗中,若用环磷酰胺和依托泊苷替代洛莫司汀和美法仑,疗效会降低。
Haematologica. 2000 Jul;85(7):722-8.
8
Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.霍奇金病治疗后发生的免疫母细胞淋巴瘤。病例报告。
Haematologica. 1986 Jan-Feb;71(1):50-2.
9
Hodgkin's disease, intracranial involvement. Report of a case and review of the literature.
Am J Clin Oncol. 1985 Feb;8(1):73-6.
10
The role of dose and rate of administration of MOPP drugs in 97 retrospective Hodgkin's patients.MOPP药物给药剂量和速率在97例回顾性霍奇金病患者中的作用。
Haematologica. 1987 Nov-Dec;72(6):523-8.